Legacy Capital Wealth Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Sell
11,251
-1,038
-8% -$46.4K 0.09% 202
2026
Q1
$592K Sell
12,289
-65
-0.5% -$3.03K 0.12% 178
2025
Q4
$599K Buy
12,354
+420
+4% +$20.8K 0.13% 171
2025
Q3
$563K Sell
11,934
-675
-5% -$32.6K 0.12% 179
2025
Q2
$609K Sell
12,609
-954
-7% -$48.7K 0.14% 158
2025
Q1
$752K Buy
13,563
+1,406
+12% +$76.1K 0.19% 115
2024
Q4
$586K Sell
12,157
-12,117
-50% -$616K 0.15% 145
2024
Q3
$1.4M Buy
24,274
+12,942
+114% +$699K 0.28% 72
2024
Q2
$550K Buy
+11,332
New +$547K 0.14% 143
2024
Q1
– Sell
-7,181
Closed -$357K – 308
2023
Q4
$357K Sell
7,181
-2,218
-24% -$108K 0.1% 195
2023
Q3
$504K Buy
+9,399
New +$501K 0.14% 145
2023
Q2
– Sell
-8,045
Closed -$438K – 204
2023
Q1
$438K Buy
+8,045
New +$391K 0.12% 148

Other funds holding SNY

Legacy Capital Wealth Partners's SNY Position: Q2 2026 in Review

Legacy Capital Wealth Partners reduced its Sanofi (SNY) stake by 8.4% in Q2 2026, selling an estimated $46.4K and leaving 11,251 shares worth $480K. The position accounts for 0.09% of the portfolio, ranked #202.

Legacy Capital Wealth Partners first reported a position in SNY in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.4M in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Legacy Capital Wealth Partners held 11,251 shares of Sanofi worth $480K as of Q2 2026.
  • Legacy Capital Wealth Partners sold 1,038 Sanofi shares in Q2 2026, an estimated $46.4K.
  • Sanofi made up 0.09% of Legacy Capital Wealth Partners's portfolio in Q2 2026, its #202 holding.
  • Legacy Capital Wealth Partners first reported a position in Sanofi in Q1 2023 and has held it in 12 quarters since.
  • Legacy Capital Wealth Partners's Sanofi position peaked at $1.4M in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.